The pharmaceutical sector and drug industry have multiple environmental challenges: eco-friendly product design, the close link between health and the environment, and drug residues in water.
The loss of active ingredients during washing or from a production batch significantly impacts a production site financially.
In this constantly evolving sector, each stage of manufacturing a drug is likely to generate polluted water:
- Organic synthesis of active ingredient precursors
- Microbiological cultures and industrial fermentation
- Extracting plant and animal tissues
- Various formulations: syrups, pastes, powders, capsules, granules, freeze-dried products
- Conditioning and packaging
We offer treatment solutions for effluents generated by focusing on reclaiming and upgrading:
Specific Cases
Construction and operation of an effluent treatment plant:
- Biological treatment with a BIOMEMBRAT® membrane bioreactor
- Polishing treatment by nanofiltration
- Physical and chemical treatment of concentrates
| Parameters | Input | Discharge |
| COD - mg/l | 8 000 | 200 |
| Sulfates - mg/l | 8 000 | 500 |
| Flow rate - m3/hr | 2 |
Construction of an effluent treatment plant:
- Biological treatment with a BIOMEMBRAT® membrane bioreactor
- Polishing treatment by nanofiltration
- Recycling organoiodine compounds in the process
| Parameters | Input | Discharge |
| COD - mg/l | 12 000 | 2 000 |
| Organoiodine compounds – g/l | 5 | 1 |
| Fow rate - m3/hr | 5 |
